The SLC5A7 gene helps nerve cells pull in choline, a nutrient they need to make acetylcholine, the signal that lets nerves activate muscles. This gene plays an important role in how nerves support movement, swallowing, and breathing. If the gene does not work well, these signals can weaken and may cause muscle weakness, low muscle tone, feeding problems, or pauses in breathing, often starting early in life. Some people with harmful SLC5A7 variants are diagnosed with a form of congenital myasthenic syndrome, a condition that affects communication between nerves and muscles.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
SLC5A7Gene function
What if the gene works
The SLC5A7 gene helps nerve cells take in choline, a building block for acetylcholine. This chemical messenger supports muscle movement, breathing, and automatic body functions such as heart rate.
Risk
What if the gene does not work
When the SLC5A7 gene does not work well, signals from nerves to muscles can weaken, causing congenital myasthenic syndrome with muscle weakness and sometimes breathing or feeding problems. Milder or more severe variants can affect symptom timing and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the SLC5A7 gene can point to treatment with pyridostigmine, which may improve weakness and reduce breathing crises. Care is then tailored to symptoms, with breathing support during severe episodes when needed.
Conditions associated with SLC5A7
Gene function
What if the gene works
The SLC5A7 gene helps certain nerve cells bring choline back inside after signals are sent. Choline is a key building block for acetylcholine, a chemical messenger used for muscle movement and many automatic body functions. This steady recycling supports clear communication between nerves, muscles, and organs.
Its protein pulls choline into nerve endings that use acetylcholine from the space outside the cell. It uses sodium, a body salt, as the driving force so uptake stays efficient even when choline levels are low.
By gathering choline, the SLC5A7 gene gives nerve cells the main raw material they need to make acetylcholine. This is a central part of how the SLC5A7 gene helps nerve cells send signals to muscles, glands, and other nerves.
After acetylcholine is broken down, some of its choline can be taken up again and reused. This helps nerve cells that use acetylcholine replenish their messenger supply during repeated, everyday signaling.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC5A7 gene can reduce choline transport by changing the transporter’s shape, lowering its stability, or keeping too little of it on the nerve cell surface. This explains how SLC5A7 gene variants affect choline transport and, in turn, acetylcholine production at the nerve ending. Milder variants may leave some activity, while more severe variants can cause a near complete loss of function and are often linked to earlier or more pronounced neuromuscular symptoms.
How variants are linked to conditions
Pathogenic variants in the SLC5A7 gene can cause congenital myasthenic syndrome, a rare inherited condition that often begins in infancy with muscle weakness, feeding trouble, droopy eyelids, or breathing pauses. This SLC5A7 gene link to congenital myasthenic syndrome is well established, and some variants have also been linked to inherited motor nerve disease with weakness affecting the arms, hands, or voice. These are rare genetic diagnoses, not common risk markers.
A variant is not necessarily a diagnosis
Gene variants are a routine feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC5A7, risk is mainly shaped by whether you inherited a disease-causing gene change, and in some families whether one or both copies are affected. There is not enough evidence that diet, exercise, or other lifestyle factors change the chance of developing an SLC5A7-related condition.
Inheritance of SLC5A7 variants
How SLC5A7 gene variants are inherited depends on the specific SLC5A7-related condition. Some conditions linked to the SLC5A7 gene follow an autosomal recessive pattern, which means a child inherits one nonworking copy from each parent, while others follow an autosomal dominant pattern, where one altered copy from either parent can be enough to cause the condition. In families asking how SLC5A7 gene variants are inherited, this means recurrence can differ depending on the diagnosis. A parent with an autosomal dominant SLC5A7-related condition may pass it on to each child with a 50% chance.
What does my SLC5A7 result mean for my family?
For SLC5A7, what this means for relatives depends on the condition linked to the result. Some SLC5A7 changes are tied to a recessive condition, so parents, brothers, sisters, and future children may want to know whether they carry the same change. Other SLC5A7 changes act in a dominant way, which can mean close relatives such as a parent, brother, sister, or child could also have the variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SLC5A7 gene, a doctor can use SLC5A7 genetic testing on a blood or saliva sample. The lab reads the gene’s DNA code and compares it with the usual sequence to look for variants. Results may show a disease-causing variant, a benign variant, or a change whose meaning is still unclear.
When should I consider getting a genetic test?
Genetic testing for the SLC5A7 gene may be considered if someone has unexplained muscle weakness, gets tired quickly with movement, has droopy eyelids, or had feeding or breathing problems starting in infancy or childhood. It can also help when this kind of nerve-and-muscle condition seems to run in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and the kind of variant present. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body processes and responds to medicines. That helps explain why the same treatment may work well for one person, seem less helpful for another, or cause more side effects in someone else. These differences are common and can affect both how strongly a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed, personalized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the SLC5A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication decisions, so general concerns about medicines, side effects, or your health are best discussed with your doctor.